In modern vaccine and biopharmaceutical development, adjuvants are no longer considered auxiliary components. They are strategic elements that directly influence immunogenicity, safety profiles, shelf life, and global distribution feasibility. Among the many challenges faced by formulation scientists, stable adjuvant formulation stands out as one of the most critical and technically...